Developed by Mapi Research Institute and managed by Mapi Research Trust (Lyon, France), ProQolid aims to identify and describe PRO and QOL instruments to help you choose appropriate instruments and facilitate your access to them. |
| |
|
This level is available to all ProQolid visitors at no charge. For each instrument in the database, you will find 14 categories of basic information (e.g., author, objective, mode of administration, original language, existing translations, pathology, number of items, etc.). Search |
|
|
| |
|
This level presents a greater degree of practical information on each instrument, most notably the author’s details and contact information, conditions of use, psychometric properties, etc., and, when available, a review copy of the original instrument, its translations, and a user manual. Login |
|
|
|
 Health and Quality of Life Outcomes's article on ProQolid »Read
ISOQOL members discount on ProQolid subscriptions »More
We're proud to include
the US FDA, the Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWIG) and the National Institute of Health (NIH)
among our growing list of ProQolid subscribers
New in ProQolid:
Now available to members, it is mentioned:
- if the questionnaire has obtained a PRO labelling claim from FDA or EMEA
- if the use of the questionnaire is recommended in a clinical research guidance (published by FDA, EMEA, NICE, etc…)
|
Descriptions of 646 instruments
500 review copies of original instruments
Review copies of 1010 translations
Review copies of 170 user manuals
Descriptions of 82 databases
NB: ProQolid content is based on information
collected in the literature and/or validated by the
authors of the instruments.
The adequacy of study methodology
and psychometric properties is not evaluated.
|
|
